Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl for Pediatric Headaches
NCT02638506Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jan 2016
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Headache comparing Intranasal Fentanyl with Placebo (2 arms). Primary endpoint: Mean pain rating reduction. Started Jan 2016; status: terminated.
02
Drugs
fentanyl
03
Conditions
Headache
Beyond the preview
Go deeper on NCT02638506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638506.